PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, IL, United States of America.\', \'Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL, United States of America.\', \'Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, United States of America.\', \'Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, United States of America.\', \'IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, United States of America.\', \'Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, United States of America.\', \'Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, MA, United States of America.\', \'The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA, United States of America.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1371/journal.ppat.1009089
?:hasPublicationType
?:journal
  • PLoS pathogens
is ?:pmid of
?:pmid
?:pmid
  • 33275640
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.006
?:rankingScore_hIndex
  • 154
?:title
  • A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all